COPD

Chronic obstructive pulmonary disease is considered a risk factor for cardiovascular diseases, which could be attributed to circulating inflammatory biomarkers. In a study, presented at the 2017 ATS...

In a recent study, researchers compared the clinical characteristics of patients with eosinophilic COPD and patients with COPD and a history of asthma.

In a recent study, researchers compared the clinical characteristics of patients with eosinophilic COPD and patients with COPD and a history of asthma.

In a recent study, researchers investigated the associations between ACE (I/D) polymorphism genotypes and treatment with ACE-I and angiotensin receptor antagonists and skeletal muscle impairment in patients...

In a recent study, researchers investigated the associations between ACE (I/D) polymorphism genotypes and treatment with ACE-I and angiotensin receptor antagonists and skeletal muscle impairment in patients...

Researchers tested whether the addition of a course of antibiotics for decreased exacerbation frequency in patients with chronic obstructive pulmonary disease.

Intravenous augmentation may slow the progression of emphysema in patients with alpha-1 antitrypsin deficiency, but other treatment options may not be effective.

Intravenous augmentation may slow the progression of emphysema in patients with alpha-1 antitrypsin deficiency, but other treatment options may not be effective.

Although rare, non-tuberculosis myocobacterial pulmonary disease (NTMPD) is associated with high risk of hospitalization and mortality.

Although rare, non-tuberculosis myocobacterial pulmonary disease (NTMPD) is associated with high risk of hospitalization and mortality.